Financial News
Latest News about ABBV
Recent news which mentions ABBV
From Motley Fool
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
Target And Chevron Get CNBC Fast Money Mentions With Joe Terranova Rebalancing His ETF
August 01, 2022
From Benzinga
If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today
July 31, 2022
From Motley Fool
3 Dividend Aristocrats to Buy in August
July 31, 2022
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
AbbVie's Q2 Sales Marginally Shy Of Wall Street Estimates, Confirms Annual Profit Outlook
July 29, 2022
Tickers
ABBV
From Benzinga
6 Unexpected Sources of Retirement Income
July 29, 2022
From Motley Fool
Earnings Scheduled For July 29, 2022
July 29, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
7 Blue-Chip Stocks to Buy on the Dip
July 27, 2022
From InvestorPlace
AbbVie Seeks Approval For Inflammatory Bowel Disease Candidate From U.S. FDA and European Medicines Agency
July 27, 2022
Tickers
ABBV
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
